logo

Verastem, Inc. (VSTM)



Trade VSTM now with
  Date
  Headline
1/6/2021 9:15:20 AM Verastem Appoints Frank Neumann As Chief Medical Officer
11/30/2020 7:11:25 AM Verastem Oncology Initiates Phase 2 Registration-Directed Trial Of VS-6766
10/28/2020 9:06:18 PM Verastem Oncology New Data Supports Potential Of VS-6766 As Treatment For RAS Mutant Tumors
10/6/2020 7:23:43 AM Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/30/2020 8:58:09 AM Verastem Completes Sale Of COPIKTRA Or Duvelisib To Secura Bio
9/16/2020 7:07:13 AM Verastem Oncology To Present Updated Phase 1/2 FRAME Study Data At Annual RAS-Targeted Drug Development Summit
8/10/2020 8:43:13 AM Verastem Oncology Signs Definitive Agreement To Sell COPIKTRA Rights To Secura Bio
7/6/2020 7:06:33 AM Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/27/2020 12:20:29 AM Verastem Oncology Presents Preliminary Data From Clinical Activity Of RAF/MEK And FAK Combination In KRAS Mutant Tumors
4/23/2020 8:41:56 AM Verastem Oncology Names John Johnson To Its Board
3/11/2020 4:10:24 PM Verastem Oncology Q4 Loss/share $0.51 Vs. Loss $0.37 Year Ago
2/28/2020 6:15:28 AM Verastem Oncology Announces New Strategic Direction To Advance Its Clinical Development Programs
2/28/2020 6:04:48 AM Verastem Agrees To Sell About 46.5 Mln Common Shares To Certain Institutional Investors
1/29/2020 7:25:59 AM Verastem Oncology Reports Dosing Of First Patient In CSPC's Chinese Study Evaluating COPIKTRA